Market Tracker

10/30 11:56am ET

Myriad Genetics Inc (NASDAQ:MYGN)

37.97
Data as of 11:41am ET
 -0.03 / -0.08%
Today’s Change
20.02
Today|||52-Week Range
42.50
+80.98%
Year-to-Date

Today’s Trading

Previous close38.00
Today’s open37.84
Day’s range37.64 - 38.30
Volume242,833
Average volume (3 months)781,770
Market cap$2.7B
Dividend yield--
Data as of 11:41am ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-22.61%
Earnings growth (next 5 years)+14.92%
Revenue growth (last year)+26.92%
P/E ratio16.9
Price/Sales3.79
Price/Book3.87

Competitors

 Today’s
change
Today’s
% change
WXWuxi Pharmatech Caym...+0.24+0.63%
ACADACADIA Pharmaceutica...+0.79+2.86%
--Cosmo Pharmaceutical...-11.95-6.38%
RCPTReceptos Inc+2.55+2.59%
Data as of 11:56am ET, 10/30/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.32
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts